Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection
Aylin Yilmaz, Magnus Gisslén, Serena Spudich et al. · 2009
Read Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection by Aylin Yilmaz, Magnus Gisslén, Serena Spudich et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006877.txt.
Description
Aylin Yilmaz and colleagues measured an HIV drug in spinal fluid in PLOS ONE in 2009. The drug is raltegravir, an integrase inhibitor. It was used in patients whose virus resisted other drug classes. HIV can shelter in the central nervous system. A drug must reach that shelter to work fully.
The team measured raltegravir concentrations in cerebrospinal fluid and plasma. Comparing the two shows how well the drug penetrates the nervous system. Poor penetration could leave a viral reservoir untreated. Good penetration supports regimens for patients with brain involvement. The measurements guide dosing where the blood-brain barrier limits access.
Catalog record
| CREATOR | Aylin Yilmaz, Magnus Gisslén, Serena Spudich et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006877